A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML.
Schwarer AP, Butler J, Jackson K, Beligaswatte A, Martin L, Kennedy G, Daniela Z, Lewis I, Hiwase D, Wight J, He S, Grigg A, Morris K, Mollee P, Marlton P.
Schwarer AP, et al. Among authors: morris k.
Hemasphere. 2018 Nov 28;2(6):e158. doi: 10.1097/HS9.0000000000000158. eCollection 2018 Dec.
Hemasphere. 2018.
PMID: 31723796
Free PMC article.